Skip to main content

A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients.

Procop GW, Shrestha NK, Vogel S, Van Sickle K, Harrington S, Rhoads DD, Rubin BP, Terpeluk P

Publication: J Clin Microbiol (2020) • Vol 58PMID: 32883744View on PubMed

Purpose

This paper compared detection of SARS-CoV-2, the virus that causes the novel 2019 coronavirus disease (COVID, COVID-19, COVID19), in saliva/oropharyngeal secretion specimens to matched nasopharyngeal swab specimens.

Conclusion

The mean cycle threshold (CT) value for SARS-CoV-2 RNA detection was significantly higher for saliva/oropharyngeal secretion specimens compared to nasopharyngeal swab specimens. Nevertheless, positive percent agreement was 100% and negative percent agreement was 99.4% for SARS-CoV-2 RNA detection between nasopharyngeal swab specimens and the matched saliva/oropharyngeal specimens.

Studies (1)

Purpose

This study compared detection of SARS-CoV-2 in saliva/oropharyngeal secretion specimens to matched nasopharyngeal swab specimens. Patients (n=216, 18-82 years old) with symptoms of COVID-19 were instructed to sniff strongly to gather nasal secretion/mucus into the oropharynx, cough to produce phlegm, and then to collect secretions and additional saliva in a sterile specimen collection container. Nasopharyngeal swab specimens were then collected by a healthcare professional (details not provided) and placed in 0.9% normal saline. Specimens were refrigerated at the collection site and then transported to the laboratory in insulated coolers with ice packs. RNA was extracted the same day as collection with the MagNA Pure System and SARS-CoV-2 RNA was detected by real-time RT-PCR using the CDC 2019 nCoV real-time RT-PCR diagnostic panel. The nasopharyngeal swab specimen result was used as the reference (CT value cut-off for a positive result not provided) to calculate the positive and negative percent agreement for the matched saliva/oropharyngeal secretion specimen.

Summary of Findings

Positive percent agreement between the nasopharyngeal and saliva/oropharyngeal specimen for SARS-CoV-2 RNA detection was 100% for the 38 nasopharyngeal specimens that were positive for SARS-CoV-2 RNA in the nasopharyngeal specimen. Negative percent agreement between the nasopharyngeal and saliva/oropharyngeal specimen was 99.4% for the remaining 178 specimens that were negative in the nasopharyngeal specimen. The one discordant case yielded a negative result in the nasopharyngeal specimen and a positive result in the saliva/oropharyngeal specimen. For this case, the presence of SARS-CoV-2 was confirmed in the saliva specimen using the Aptima SARS-CoV-2 transcription-mediated amplification assay. The mean CT value for SARS-CoV-2 RNA detection was significantly higher for saliva/oropharyngeal secretion specimens compared to nasopharyngeal swab specimens (24.16 versus 20.55, P=0.022) and there was no correlation between the CT values of the positive saliva/oropharyngeal secretion specimens and nasopharyngeal specimens (r=0.162; P=0.333).

  • Biospecimens

    FluidSaliva
    CellNasopharynx
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Pneumonia/Respiratory Infection
  • Platforms

    RNAReal-time qRT-PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionBiospecimen location
    Nasopharynx
    Oral cavity/oropharynx
    Biospecimen AcquisitionMethod of cell acquisition
    Nasopharyngeal swab
    Saliva/oropharyngeal secretion
    Real-time qRT-PCR SpecificTargeted nucleic acid
    SARS-CoV-2